Implementation Of A Treat-to-target Remission Strategy For Rheumatoid Arthritis In Australian Public And Private Rheumatology Clinics
Funder
National Health and Medical Research Council
Funding Amount
$178,157.00
Summary
Rheumatoid arthritis (RA) is a common and incurable inflammatory joint disease affecting 2% of Australians. RA is associated with significant pain, disability, loss of work capacity and reduced life expectancy. Research has shown that 'treating to a target' for the goal of remission significantly improves outcomes for people living with RA. This TRIP fellowship will assess the barriers to clinicians and people living with RA managing the disease in a targeted way and develop a package to assist.